Knez L - Search Results

1

Adverse drug events during transitions of care : Randomized clinical trial of medication reconciliation at hospital admission.

Jošt M, Knez L, Mrhar A, Kerec Kos M. Jošt M, et al. Among authors: knez l. Wien Klin Wochenschr. 2022 Feb;134(3-4):130-138. doi: 10.1007/s00508-021-01972-2. Epub 2021 Nov 24. Wien Klin Wochenschr. 2022. PMID: 34817667 Clinical Trial.

2

The need for medication reconciliation: a cross-sectional observational study in adult patients.

Knez L, Suskovic S, Rezonja R, Laaksonen R, Mrhar A. Knez L, et al. Respir Med. 2011 Oct;105 Suppl 1:S60-6. doi: 10.1016/S0954-6111(11)70013-0. Respir Med. 2011. PMID: 22015089 Free article.

3

Oral treatment with etoposide in small cell lung cancer - dilemmas and solutions.

Rezonja R, Knez L, Cufer T, Mrhar A. Rezonja R, et al. Among authors: knez l. Radiol Oncol. 2013 Mar;47(1):1-13. doi: 10.2478/raon-2013-0008. Epub 2013 Feb 1. Radiol Oncol. 2013. PMID: 23450046 Free PMC article.

4

Effectiveness of pharmacist-led medication reconciliation on medication errors at hospital discharge and healthcare utilization in the next 30 days: a pragmatic clinical trial.

Jošt M, Kerec Kos M, Kos M, Knez L. Jošt M, et al. Among authors: knez l. Front Pharmacol. 2024 Mar 28;15:1377781. doi: 10.3389/fphar.2024.1377781. eCollection 2024. Front Pharmacol. 2024. PMID: 38606174 Free PMC article.

5

Deprescribing: An umbrella review.

Japelj N, Horvat N, Knez L, Kos M. Japelj N, et al. Among authors: knez l. Acta Pharm. 2024 May 30;74(2):249-267. doi: 10.2478/acph-2024-0011. Print 2024 Jun 1. Acta Pharm. 2024. PMID: 38815201 Free article.

6

Time to access to novel anticancer drugs and the correlation with ESMO-Magnitude of Clinical Benefit Scale in Slovenia.

Janzic U, Knez L, Janzic A, Cufer T. Janzic U, et al. Among authors: knez l. Expert Rev Pharmacoecon Outcomes Res. 2019 Dec;19(6):717-723. doi: 10.1080/14737167.2019.1702879. Epub 2019 Dec 11. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 31826655

7

Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Real-World Data from an Academic Central and Eastern European Center.

Ivanović M, Knez L, Herzog A, Kovačević M, Cufer T. Ivanović M, et al. Among authors: knez l. Oncologist. 2021 Dec;26(12):e2143-e2150. doi: 10.1002/onco.13909. Epub 2021 Aug 2. Oncologist. 2021. PMID: 34288239 Free PMC article.

8

Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer.

Pelicon V, Cufer T, Knez L. Pelicon V, et al. Among authors: knez l. Front Oncol. 2023 Jun 19;13:1182748. doi: 10.3389/fonc.2023.1182748. eCollection 2023. Front Oncol. 2023. PMID: 37404771 Free PMC article.

9

Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting.

Lekic M, Kovac V, Triller N, Knez L, Sadikov A, Cufer T. Lekic M, et al. Among authors: knez l. Radiol Oncol. 2012 Mar;46(1):54-9. doi: 10.2478/v10019-012-0007-1. Epub 2012 Jan 2. Radiol Oncol. 2012. PMID: 22933980 Free PMC article.

10

Population pharmacokinetics of cisplatin in small cell lung cancer patients guided with informative priors.

Aguiar Zdovc J, Vaupotič M, Marolt G, Knez L, Režonja Kukec R, Čufer T, Vovk T, Grabnar I. Aguiar Zdovc J, et al. Among authors: knez l. Cancer Chemother Pharmacol. 2022 Oct;90(4):301-313. doi: 10.1007/s00280-022-04465-9. Epub 2022 Aug 20. Cancer Chemother Pharmacol. 2022. PMID: 35986742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters